Trial intelligence / Profile preview

Oxytocin Bolus vs Infusion in Elective Cesarean Section

NCT05236985Phase 4Recruiting

Sponsor
Stony Brook University
Start
Mar 2022
Primary completion
Dec 2024
Modality
Peptides
Countries
1
01

Overview

A Phase 4 trial of oxytocin in uterine atony, postpartum hemorrhage (PPH), sponsored by Stony Brook University. Started Mar 2022; status: recruiting.

02

Drugs

oxytocin
03

Conditions

uterine atonypostpartum hemorrhage (PPH)

Beyond the preview

Go deeper on NCT05236985.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05236985.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call